Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells.
暂无分享,去创建一个
[1] D. Ganem,et al. Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells. , 2011, Virology.
[2] D. Ganem,et al. Array-Based Transcript Profiling and Limiting-Dilution Reverse Transcription-PCR Analysis Identify Additional Latent Genes in Kaposi's Sarcoma-Associated Herpesvirus , 2010, Journal of Virology.
[3] T. Seo,et al. Centrifugal enhancement of Kaposi's sarcoma-associated virus infection of human endothelial cells in vitro. , 2008, Journal of virological methods.
[4] D. Ganem,et al. Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent. , 2008, Virology.
[5] C. Rinaldo,et al. Human Herpesvirus 8 Infects and Replicates in Primary Cultures of Activated B Lymphocytes through DC-SIGN , 2008, Journal of Virology.
[6] W. Greene,et al. Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation , 2006, The Journal of experimental medicine.
[7] J. Webster-Cyriaque,et al. Oral EBV and KSHV Infection in HIV , 2006, Advances in dental research.
[8] D. Ganem,et al. KSHV infection and the pathogenesis of Kaposi's sarcoma. , 2006, Annual review of pathology.
[9] N. Perico,et al. Cyclosporine Formulation and Kaposi’s Sarcoma after Renal Transplantation , 2005, Transplantation.
[10] A. Rickinson,et al. Regression of Epstein-Barr Virus-Induced B-Cell Transformation In Vitro Involves Virus-Specific CD8+ T Cells as the Principal Effectors and a Novel CD4+ T-Cell Reactivity , 2005, Journal of Virology.
[11] J. Vieira,et al. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. , 2004, Virology.
[12] D. Ganem,et al. Hepatitis B virus infection--natural history and clinical consequences. , 2004, The New England journal of medicine.
[13] P. Pellett,et al. Comparison of human herpesvirus 8 and Epstein–Barr virus seropositivity among children in areas endemic and non‐endemic for Kaposi's sarcoma , 2004, Journal of medical virology.
[14] J. Levy. The search for the CD8+ cell anti-HIV factor (CAF). , 2003, Trends in immunology.
[15] J. Goedert,et al. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma , 2003, AIDS.
[16] D. Ganem,et al. Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells , 2003, Journal of Virology.
[17] P. Stewart,et al. Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. , 2002, The Journal of infectious diseases.
[18] Shou-Jiang Gao,et al. Efficient Infection by a Recombinant Kaposi's Sarcoma-Associated Herpesvirus Cloned in a Bacterial Artificial Chromosome: Application for Genetic Analysis , 2002, Journal of Virology.
[19] F. Chisari,et al. Blocking Chemokine Responsive to γ–2/Interferon (IFN)-γ Inducible Protein and Monokine Induced by IFN-γ Activity In Vivo Reduces the Pathogenetic but not the Antiviral Potential of Hepatitis B Virus–specific Cytotoxic T Lymphocytes , 2001, The Journal of experimental medicine.
[20] M Roederer,et al. HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. , 2001, Immunity.
[21] C. Hillyer. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection , 2001 .
[22] F. Chisari,et al. Characterization of Nuclear RNases That Cleave Hepatitis B Virus RNA near the La Protein Binding Site , 2001, Journal of Virology.
[23] B. Chandran,et al. Activation of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Lytic Replication by Human Cytomegalovirus , 2001, Journal of Virology.
[24] A. Wald,et al. Mucosal shedding of human herpesvirus 8 in men. , 2000, The New England journal of medicine.
[25] J. Levy,et al. The restricted cellular host range of human herpesvirus 8 , 2000, AIDS.
[26] M. Corbellino,et al. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. , 2000, The American journal of pathology.
[27] P. Monini,et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. , 1999, Blood.
[28] C. Pellet,et al. Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF). , 1999, Transplantation.
[29] R. Sun,et al. Cellular Tropism and Viral Interleukin-6 Expression Distinguish Human Herpesvirus 8 Involvement in Kaposi’s Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman’s Disease , 1999, Journal of Virology.
[30] E. van Marck,et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[31] A. Palestine,et al. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. , 1999, The New England journal of medicine.
[32] F. Chisari,et al. Hepatitis B Virus RNA-Binding Proteins Associated with Cytokine-Induced Clearance of Viral RNA from the Liver of Transgenic Mice , 1999, Journal of Virology.
[33] D. Ganem,et al. Limited Transmission of Kaposi’s Sarcoma-Associated Herpesvirus in Cultured Cells , 1998, Journal of Virology.
[34] F. Chisari,et al. Inhibition of Hepatitis B Virus Replication during Adenovirus and Cytomegalovirus Infections in Transgenic Mice , 1998, Journal of Virology.
[35] F. Chisari,et al. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice , 1997, Journal of virology.
[36] J. Russo,et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Bell,et al. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis , 1996, Nature Medicine.
[38] J. Lieberman,et al. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients , 1996, The Journal of experimental medicine.
[39] G. Boiteau,et al. J. Virol. Methods , 1996, Journal of Virological Methods.
[40] F. Chisari,et al. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[41] S. Rafii,et al. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells , 1996, The Journal of experimental medicine.
[42] J. Levy,et al. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. , 1996, Immunology today.
[43] I. Penn,et al. Sarcomas in organ allograft recipients. , 1995, Transplantation.
[44] E. Cesarman,et al. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. , 1995, Blood.
[45] F. Sigaux,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.
[46] E. Cesarman,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.
[47] P. Moore,et al. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. , 1995, The New England journal of medicine.
[48] J. Ambroziak,et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. , 1995, Science.
[49] V. Calvez,et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma , 1995, The Lancet.
[50] J. Levy,et al. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[51] E. Cesarman,et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.
[52] J. Levy,et al. Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor. , 1994, Cellular immunology.
[53] O. Chilson,et al. Mitogenic lectins bind to the antigen receptor on human lymphocytes , 1989, European journal of immunology.
[54] M. Zutter,et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. , 1988, Blood.
[55] B. Burke,et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. , 1988, Blood.
[56] P. Lipsky,et al. Differential ability of fixed antigen-presenting cells to stimulate nominal antigen-reactive and alloreactive T4 lymphocytes. , 1986, Journal of immunology.
[57] I. Ernberg,et al. Effect of cyclosporin‐A (CsA) on the ability of T lymphocyte subsets to inhibit the proliferation of autologous EBV‐transformed B cells , 1985, International journal of cancer.
[58] M. Crumpton,et al. Phaseolus vulgaris phytohaemagglutinin (PHA) binds to the human T lymphocyte antigen receptor. , 1984, The EMBO journal.
[59] J. Oppenheim,et al. Antigen presentation by human monocytes: evidence for stimulant processing and requirement for interleukin 1. , 1983, Journal of immunology.
[60] S. McLachlan,et al. Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein–Barr virus-induced B-cell lines , 1981, Nature.
[61] J. H. Pope,et al. Long‐term T‐cell‐mediated immunity to epstein‐barr virus in man. IV. Development of T‐cell memory in convalescent infectious mononucleosis patients , 1980, International journal of cancer.
[62] J. H. Pope,et al. Long‐term T‐cell‐mediated immunity to Epstein‐Barr virus in man. III. Activation of cytotoxic T cells in virus‐infected leukocyte cultures , 1979, International journal of cancer.
[63] J. H. Pope,et al. Long‐term T‐cell‐mediated immunity to Epstein‐Barr virus in man. II. Components necessary for regression in virus‐infected leukocyte cultures , 1979 .
[64] F. Chisari,et al. Noncytolytic control of viral infections by the innate and adaptive immune response. , 2001, Annual review of immunology.
[65] C. Pellet,et al. Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF). , 1999, Transplantation.